Suppr超能文献

维拉帕米在大鼠和人肝脏微粒体组分存在下O-去甲基化的区域化学和底物立体选择性。

Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.

作者信息

Nelson W L, Olsen L D, Beitner D B, Pallow R J

机构信息

Dept. of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle 98195.

出版信息

Drug Metab Dispos. 1988 Mar-Apr;16(2):184-8.

PMID:2898330
Abstract

The oxidative O-demethylation of verapamil (1), a calcium channel antagonist, in the presence of rat and human liver microsomes was examined. By using GC/MS methodology and synthesized regioisomeric standards, we showed that three of the four possible monophenolic metabolites, alpha-[3-([2-(3,4-dimethoxyphenyl)ethyl]methyl-amino) propyl]-3-methoxy-4-hydroxy-alpha-(1-methylethyl)phenyl-acetonitrile (2), alpha-[3-([2-(3,4-methoxyphenyl)ethyl]methyl-amino) propyl]-3-hydroxy-4-methoxy-alpha-(1-methylethyl)phenylaceto nitrile (3), and alpha-[3-([2-(3-methoxy-4-hydroxyphenyl)ethyl]methylamino) propyl]-3,4-dimethoxy-alpha-(1-methylethyl)phenylacetonitrile (4) were formed. The other possible regioisomeric monophenolic metabolite 5 was not observed. Substrate stereoselectivity for the O-demethylation process was determined when pseudoracemic verapamil [equimolar (S)-(-)-verapamil-d6 and (R)-(+)-verapamil-d0] was used as substrate. In the presence of rat liver microsomes, significant substrate stereoselectivity was observed for formation of 4 (S/R ratio 2.28), whereas marginal substrate stereoselectivity was observed in the formation of both 3 and 2 (S/R ratio approximately 0.8). Substrate stereoselectivity for the O-demethylation process in the presence of human liver microsomes was slight and variable (six samples). Quantitatively, the ratio of O-demethylation products obtained (4:2:3) was similar in the presence of rat and human liver microsomes. In both systems, more than one-half of the total O-demethylation occurred in the aromatic ring of the phenethylamine moiety, and of the total O-demethylation process, more para- than meta-O-demethylation was observed. The similarity of regioselectivity for O-demethylation in the presence of rat and human liver microsomes suggests a similar cytochrome P-450 isozyme or set of isozymes may be responsible for the O-demethylation process.

摘要

研究了钙通道拮抗剂维拉帕米(1)在大鼠和人肝微粒体存在下的氧化O-去甲基化反应。通过使用气相色谱/质谱方法和合成的区域异构体标准品,我们发现四种可能的单酚代谢产物中的三种,即α-[3-([2-(3,4-二甲氧基苯基)乙基]甲基氨基)丙基]-3-甲氧基-4-羟基-α-(1-甲基乙基)苯基乙腈(2)、α-[3-([2-(3,4-甲氧基苯基)乙基]甲基氨基)丙基]-3-羟基-4-甲氧基-α-(1-甲基乙基)苯基乙腈(3)和α-[3-([2-(3-甲氧基-4-羟基苯基)乙基]甲基氨基)丙基]-3,4-二甲氧基-α-(1-甲基乙基)苯基乙腈(4)被形成。未观察到另一种可能的区域异构体单酚代谢产物5。当使用伪外消旋维拉帕米[等摩尔的(S)-(-)-维拉帕米-d6和(R)-(+)-维拉帕米-d0]作为底物时,测定了O-去甲基化过程的底物立体选择性。在大鼠肝微粒体存在下,观察到在形成4时具有显著的底物立体选择性(S/R比为2.28),而在形成3和2时观察到边缘底物立体选择性(S/R比约为0.8)。在人肝微粒体存在下,O-去甲基化过程的底物立体选择性轻微且变化不定(六个样品)。定量地,在大鼠和人肝微粒体存在下获得的O-去甲基化产物的比例(4:2:3)相似。在两个系统中,超过一半的总O-去甲基化发生在苯乙胺部分的芳环上,并且在总O-去甲基化过程中,观察到对位O-去甲基化多于间位O-去甲基化。在大鼠和人肝微粒体存在下O-去甲基化区域选择性的相似性表明,一种相似的细胞色素P-450同工酶或一组同工酶可能负责O-去甲基化过程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验